Benito Menni C.A.S.M., Barcelona, Spain
Department of Psychiatry, Cambridge University School of Medicine
Department of Anaesthesiology, Addenbrooke's Hospital, Cambridge
Fulbourn Hospital, Cambridge
Department of Psychiatry, Cambridge University School of Medicine, Cambridge, UK
Correspondence: Dr P. J. McKenna, Section of Psychological Medicine, Gartnavel Royal Hospital, 1055 Great Western Road, Glasgow G12 0XH, UK. Email: ppeter.eter.mckenna{at}virgin.net
Background The psychosis-inducing effect of ketamine is important evidence supporting the glutamate hypothesis of schizophrenia. However, the symptoms the drug produces have not been described systematically.
Aim To examine the effects of ketamine in healthy people using a structured psychiatric interview.
Method Ketamine (200 ng/ml) or placebo was administered by continuous infusion to 15 healthy volunteers. Symptoms were rated using the Present State Examination, the Thought, Language and Communication Scale and the Scale for Assessment of Negative Symptoms.
Results Ketamine induced a range of perceptual distortions, but not hallucinations. Referential ideas were seen in nearly half the sample. There were only mild and infrequent ratings on the thought disorder scale. Affective flattening and alogia were seen in some volunteers.
Conclusions Ketamine does not reproduce the full picture of schizophrenia. The main point of similarity concerns referential thinking. Phenomena resembling negative symptoms are also seen, butthe distinction of these from the drug's sedative effects requires further elucidation.
Related articles in BJP:
This article has been cited by other articles:
![]() |
A Newton and L Fitton Intravenous ketamine for adult procedural sedation in the emergency department: a prospective cohort study Emerg. Med. J., August 1, 2008; 25(8): 498 - 501. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. W. Deakin, J. Lees, S. McKie, J. E. C. Hallak, S. R. Williams, and S. M. Dursun Glutamate and the Neural Basis of the Subjective Effects of Ketamine: A Pharmaco-Magnetic Resonance Imaging Study Arch Gen Psychiatry, February 1, 2008; 65(2): 154 - 164. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Absalom, M. Lee, D. K. Menon, S. R. Sharar, T. De Smet, J. Halliday, M. Ogden, P. Corlett, G. D. Honey, and P. C. Fletcher Predictive performance of the Domino, Hijazi, and Clements models during low-dose target-controlled ketamine infusions in healthy volunteers Br. J. Anaesth., May 1, 2007; 98(5): 615 - 623. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Stone and L. S. Pilowsky Psychopathological consequences of ketamine The British Journal of Psychiatry, December 1, 2006; 189(6): 565 - 566. [Full Text] [PDF] |
||||